I am a molecular endocrinologist and aquatic ecotoxicologist with an interest in the effects of endocrine active chemicals on aquatic wildlife. I am also active in research to protect humans from diseases associated with exposure to biological contaminants in freshwater, including legionella (pathogenic bacteria) and schistosomiasis (parasitic disease) - see my grants for more details. I have published over 30 papers that have been collectively cited over 5500 times. I am programme leader for the Masters in Sustainability, Entrepreneurship and Design which aims to provide entrepreneurial students with the skills and mind-set to help build a sustainable future; one that is environmentally responsible and socially inclusive. I teach a number of subjects at Masters level, including Ecology, Sustainability, and Toxicology (Endocrine Disruption). Research Projects: I have a broad background in ecotoxicology research through the use of in vitro and in vivo (mammalian and aquatic) test systems for environmental estrogens, studies into quantitative structure activity relationships of alkylphenolic chemicals, the application of solid-phase extraction techniques for analysing complex environmental samples, and studies into the molecular mechanisms of estrogen receptor action, to name a few. My present research interests include the application of freshwater mollusc species in environmental monitoring and regulatory testing of chemicals, fundamental research on the molecular endocrinology of freshwater molluscs and the effect of pollution on parasite-host interactions. Recent awards involving SMEs and from industry have a strong focus around water quality issues, from the health effects of consuming direct potable reuse water, validation of the efficacy of a novel device to kill pathogenic bacteria in hot water systems, and the development of ballast water treatment systems to prevent the spread of invasive species in aquatic ecosystems.

My research interests can be divided into the following areas: 1. Ecotoxicology: The effects of endocrine disrupting chemicals (EDCs) on freshwater wildlife (fish and molluscs), including the effects of chemical pollutants on parasite host interactions. New and emerging contaminants (e.g. microplastics). 2. Animal Welfare and Regulatory Testing: The use of molluscs as replacements to vertebrates in regulatory chemical testing strategies. Includes fundamental biology research. 3. Technological interventions and Health: The prevention and control of pathogenic bacteria (Legionella) in domestic water systems. 4. Neglected Tropical Diseases: Developing novel approaches to control the transmission of schistosomiasis in humans. 6. Fresh water sustainability: The potential health effects of indirect potable reuse water (advanced treatment technologies) being developed to help meet societies’ demand for drinking water.

I obtained a PhD in Environmental Science from The University of New South Wales in 1995 (thesis was submitted for examination in 1994). Before joining University of Salford, I held senior academic positions at University of Southern Queensland and South China Agricultural University. Earlier academic appointments were with Southern Cross University, The University of New South Wales and South China Normal University. I also worked as a professional environmental consultant with a global consulting company (Brisbane Office, Golder Associates) during the period from 2005 to 2009. I am an Associate Editor for Journal of Environmental Management (Elsevier; impact factor: 4.010) with direct responsibility for making final decision on manuscripts (over 110 manuscripts per year). TEACHING I have teaching interests in environmental science, environmental management, environmental chemistry, environmental impact assessment, environmental technology, soil science and restoration ecology.

I have a broad range of research interests in environmental sciences with a particular focus on environmental issues related to acid sulfate weathering in mine areas (acid mine drainage) and coastal lowlands (acid sulfate soils). More recently, much effort has been made to develop cost-effective technologies for remediation of petroleum hydrocarbon-contaminated soils with a special reference to the Kuwait oil lake areas, an environmental legacy of the first Gulf War. Other research interests include chemical behaviour of heavy metals and pesticides in water-soil-plant systems, characterization and treatment of industrial wastes, ecotoxicology, soil carbon sequestration, climate change adaptation, and payment for environmental services (PES).

Manuela Marcoli has completed her M.D. degree at the age of 24 years from Pavia University, Italy (PhD. Degree in Clinical Pharmacology from Pavia University, Italy). She is professor of Pharmacology at the University of Genova, Italy. She has over 85 publications that have been cited over 1300 times, and her publication H-index is 22 and has been serving as a reviewer of reputed Journals

Pharmacology and Toxicology

Education: Faculty of Pharmacy, Medical University, Lublin, Poland; Master’s degree (highest honor), Department of Biochemistry; Doctoral thesis in pharmacology (highest honor), Department of Pharmacodynamics; Habilitation thesis in Pharmacology (highest honor), idem; since 2010–Full Professor degree, now: the Head of the Chair and Department of Pharmacology and Pharmacodynamics; since 2012 – Vice-Dean of the Faculty of Pharmacy with Medical Analitics Division, Medical University of Lublin, Poland. 1991-2009: Recipient of seven fellowships of French and Polish Government; in total 5 years of training and regular post in Paris; 9 Erasmus Plus training. Author of 230 papers, tutor of 10 doctoral thesis, number of citations: 1500; citation index=22. Review of papers for international and polish journals: 233; of scientific grants: 117, principle investigator of polish and international (”Polonium”) grants and UE projects. Member of 15 Editorial Board of open-access journals. Member of the Polish Academy of Science Commissions. Languages: Polish: native; French: fluently; English, Russian. Research subjects: psychopharmacology, pharmacotherapy, experimental pharmacology. The central effects of psychoactive drugs and natural products (including locomotor sensitization, cross-sensitization, place conditioning and withdrawal syndrome, chronic mild unpredictable stress), anxiety, memory and learning, depression, nociception, Parkinson and Alzheimer disease, psychosis, measured in behavioral paradigms. The common molecular mechanisms shared by addiction and memory processes; the neurobiological mechanisms of drug dependence (the influence of endocannabinoid system, calcium homeostasis and kinases/phosphatases balance) and further strategies for its pharmacotherapy.

Her research interests include: the regulation and suppression of human UGTs and their role as anti-proliferative agents in cancer models, the interactions between UGTs and cannabinoid receptors, the delivery of UGT genes and drugs into cancer cells using nanomaterials, and the roles of UGTs in the biotransformation of drugs including resveratrols and drugs of abuse such as marijuana and synthetic cannabinoids.

EDUCATION 2018 - Senior Research Associate 2010 - PhD in Molecular Biology, Faculty of Biology (FB), UB (THESIS: Analysis of gene variants in chronic obstructive pulmonary disease in humans) 2003 - BSc in Molecular Biology and Physiology, FB, University of Belgrade. 2013 - 2015 - Postdoc Fellow, Feinberg graduate school, Weizmann Institute of Science, Rehovot, Israel 2011 - 2012 - assistant coordinator of the project: Complex diseases as a model system for phenotype modulation - structural and functional analysis of molecular biomarkers - Pulmonary phenotype, MESTDS, 173008 2011 – 2011 - Lecturer on PhD programme in Molecular Biology, Faculty of Biology, University of Belgrade, Subject: Molecular genetic in the diagnostic, prevention and therapy of human diseases 2013 - Reviewer in American Journal of Biomedical Research 2012 - membership Oxygen Club of California 2004 - membership European Respiratory Society

- respiratory disorders: COPD, bronchiectasis, asthma, etiopathology of emphisematous and fibrotic lesions, inflammation and oxidative stress of the lungs - approaches: genetic association studies, gene expressions, gene-environment interactions, phenotype modulation, biomarkers

Assistant Professor, Department of Pharmacology, Faculty of Pharmacy, University Complutense of Madrid (Spain). Member of the Research Group “Pharmacology of Natural Products”. I obtained my European PhD in Pharmacy in 2012 (Extraordinary Doctoral Prize). I had worked for 3 years in the Spanish Agency of Medicines and Medical Devices (AEMPS). Expertise in the study of natural products from medicinal plants and lichens as neuroprotective agents, based on their antioxidant properties, against different models of oxidative stress in cell lines of the nervous system (neurons and astrocytes). Author of many scientific publications (25 in indexed journals, 4 in non-indexed journals and 9 chapters of books) as well as communications in national and international congresses. I have participated as researcher in four National funded projects and research stays at prestigious international centers (King’s College of London and Neuroscience Center in Coimbra). Teaching experience at all levels of higher education in Pharmacology, Toxicology and Pharmacognosy subjects as well as experience in Educational Innovative Projects.

Study of natural products from medicinal plants and lichens as neuroprotective agents, based on their antioxidant properties, against different models of oxidative stress in cell lines of the nervous system (neurons and astrocytes)

He was born in the city of Jiquilpan, Michoacán, Mexico.He studied a degree in medicine at the Michoacán University of San Nicolás de Hidalgo (UMSNH). He obtained training to be a professor in Pharmacology and Toxicology at the National Autonomous University of Mexico (UNAM). He obtained the postgraduate degree of Expert and International Master in Toxicology at the Illustrious Official School of Chemists of Seville, Spain.He participated in the following FAO courses: "International Code of Conduct for Pesticide Management" and "International Code of Conduct for Pesticide Distribution and Storage". He is a member of the Spanish Association of Toxicology (AETOX) and the European Association of Toxicology (EUROTOX).In addition, he is also a member of the following groups: EHSQ Elite (No.1 IN SAFETY) Enviromental Health Safety Sustainability Security Elite, Regulatory Toxicology Group, Society of Cosmetic Scientists-SCS Group, EUSAAT- EUROPEAN SOCIETY FOR ALTERNATIVES TO ANIMAL TESTING, Eurotox 2017, REACH, CLP and Biocides Regulations and Genetic Literacy Project. He is dedicated to the private practice of General Toxicology with a focus on treatment and design of strategies in the problem of agrochemicals. Since 1995, he has provided advice to health institutions, educators, day laborers and small producers, providing information on the risks that the inadequate management of agrochemicals has as a consequence. He has participated as an organizer and speaker of courses and conferences in the region and in the State.He currently works as a consultant and altruistic consultant in the two universities of the state and in the ecology council of the state (COEECO), which is the only one in the country.

He is dedicated to the private practice of General Toxicology with a focus on treatment and design of strategies in the problem of agrochemicals.

Philip Wexler is a Technical Information Specialist at the National Library of Medicine’s (NLM) Toxicology and Environmental Health Information Program (TEHIP) and federal liaison to the Toxicology Education Foundation. He is the Editor-in-Chief of three editions of the Encyclopedia of Toxicology (Elsevier. 3rd ed. 2014), four editions of Information Resources in Toxicology (Elsevier. 4th ed. 2009), Chemicals, Environment, Health: A Global Management Perspective (CRC Press/Taylor and Francis. 2011), and the Taylor and Francis journal, Global Security: Health, Science, and Policy. He is also overseeing an Elsevier monographic series on Toxicology History. Two volumes on Toxicology in Antiquity have been published and a follow-up on Toxicology in the Middle Ages and Renaissance is scheduled for publication in March, 2017. He is a recipient of the NLM Regents Award for Scholarly or Technical Achievement and the US Society of Toxicology’s Public Communications Award.

Toxicoinformatics, including online database building, enhancing, and searching, Toxicology Education and Communication, Toxicology History

Pierre Eftekhari has completed his PhD from Strasbourg University. He has more than 19 years of experience in Drug Development and is the President of Inoviem Scientific, a company dedicated to cutting edge solutions in drug development. He has published more than 30 papers in reputed journals and filed several patents.

Drug Development, Drug Discovery, Toxicology

Eric Ezan studied Biological Engineering at the University of Compiegne, France. After a first experience at the University of Waterloo (Ontario), he obtained a PhD degree at the University Paris V in Pharmacological Sciences (1989). He then joined the Institute Pasteur of Paris for two-year Post-doctoral experience. He was recruited by the CEA (Alternative Energies and Atomic Energy Commission) in 1991, where he became the Head of the Laboratory for Drug Metabolism at the CEA in 2000. This laboratory located at Saclay, south of Paris, is involved in the development of immunological methods and mass spectrometry for the discovery of biomarkers and quantification of small molecular weight drugs and biologicals for preclinical and clinical applications. The laboratory also became a leader in the use of mass spectrometry approaches for the detection biological weapons. In 2014, he joined the CEA Program for the development of health technology.

Drug Metabolism, Biomarkers, Pre-clinical and Clinical Studies

Farhan Sahito is a Senior Project Manager for the SIIP EU funded project (Speaker Identification Integrated Project) at INTERPOL. Mr. Sahito has done his Ph.D. in at Graz University of Technology Austria. His research aims to advance Cyber Crime detection methods for the protection of infrastructures and e-businesses from financially, politically and socially incentivized cyber threats. He has done Master's in Information Technology from Pakistan and Master's in Criminology from University of Melbourne, Australia. Mr. Sahito has been working with Pakistan police since 2002. Before joining INTERPOL as a Senior Project Manager, he was working as Deputy Director in Cyber Crime Department in the Federal Investigation Agency Pakistan.

His research interests include cybercrime, law enforcement, digital forensic investigations, biometrics, financial investigation

José Fernando Santos Almeida is a Psychiatrist and completed his PhD from Instituto de Ciências Biomédicas Abel Salazar (Universidade do Porto). He is a Professor and President of Scientifi c Council of Instituto Universitário da Maia and Editor-Chief of Psiquiatria, Psicologia & Justiça.

Toxicology, Psychiatry

Plant physiologist, B. Schoefs graduated from the Botany Department at the Liège University, Belgium in 1994. He worked for the Liège University, the South Bohemia University, the CNRS. He became Professor in Plant Physiology at the University of Dijon, France. In 2011, he joined the University of Le Mans, France. He is the leader of the ‘Metabolism and engineering of microalgal molecules and applications’ research group. He has published more than 70 papers, edited books, monographies and special issues. He is a member of the editorial board of Frontiers in Plant Science, Communicative and Integrative Biology and Botany Letters. He won the Prize Clos from the Toulouse Academy of Sciences, France and the annual scientific competition of the Belgian Academy of Science.

His research is focuses on the physiological (photosynthesis, respiration), biochemical (carbon metabolism, pigments) and molecular responses (transcription factors) of photosynthetic organisms, including algae, to biotic or abiotic stresses.

Anna Radominska Pandya serves as a Professor in the Department of Biochemistry and Molecular Biology at UAMS; and she is the Editor in Chief for Drug Metabolism Review. She received her PhD from the Institute of Biochemistry and Biophysics, Polish Academy of Sciences in Warsaw, Poland. She has published 175 papers in various peer-reviewed journals, and she has received twelve R01 grants from the NIH and DoD. Her research interests include: The regulation and suppression of human UGTs and their role as anti-proliferative agents in cancer models, the interactions between UGTs and cannabinoid receptors, the delivery of UGT genes and drugs into cancer cells using nanomaterial, and the roles of UGTs in the biotransformation of drugs including resveratrols and drugs of abuse such as marijuana and synthetic cannabinoids.

Biochemistry, Molecular Biology, Drug Metabolism, Toxicology and Biotransformation

Yazan Akkam has completed his PhD from University of Arkansas and Post-doctoral studies on Nanotoxicity from Institute for Nanosciences and Engineering, Arkansas. He is the Head of Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Jordan. Also, he is a Member of the National Committee for the Management of Nanomaterials- Ministry of Environment, Jordan.

Nano Toxicology, Nano-sciences and Engineering, Pharmaceutical Sciences

Manju Sharma is an MD and Doctor of Naturopathy working currently as a Scientist at Vancouver Prostate Centre, Vancouver General Hospital, Canada for the last 10 years. Prior to this, she worked in the Department of Pathology and Lab Medicine, VGH for 10 years on various projects including molecular diagnosis of tuberculosis, multi-drug resistant tuberculosis, human solid tumors, kidney disorders, medicinal herbal plants like Echinacea which is widely used all over Europe and North America for the treatment of cough and cold: Active principles and their mode of action on various human viral and bacterial diseases. She has published over 75 papers in medical journals and has made several presentations in the fi eld of Medicine.

Medicine, Cancer Biology, Herbal Medicines, Toxicology

Stefano Bonassi is a Doctor in Biological Sciences - University of Genova and a Specialist in Medical Statistics and Epidemiology - University of Pavia. He is a Faculty for PhD programs in Human Genetics of the Universidad Autonoma de Barcelona, Barcelona, Spain, and M2E2 International courses of Molecular Epidemiology of Chronic Diseases at the Maastricht University, the Netherlands. He is a reviewer of many journals such as Experimental Research; Mutagenesis; Cancer Epidemiology; Biomarkers & Prevention et al.

Cancer Epidemiology, Toxicology, Biomarkers, Nano Toxicology

Swamy K B has been awarded PhD by Andhra University, India. He has taken his Master’s Degree i.e., MS (in Clinical Anatomy) from Andhra Medical College, India. He took his Medical Degree (MBBS) in 1976. He is specialized in Human Genetics and Herbal Medicine. He has conducted many researches on Herbal Medicine and Diabetes and “Brain size and Intelligence Quotient (IQ)” on which he has conducted researches and has published more than 25 research papers in high impact factor indexed international journals. He is a founder Anatomist for many Medical Universities in Malaysia. He is the former Professor and Head of the Department of Anatomy for many Medical Schools in India and Malaysia. He has been serving as an Editorial Board Member for many reputed journals.

Clinical Toxicology, Herbal Medicine, Diabetes, Human Genetics

Marcelo L. Larramendy, Ph.D., serves as Professor of Molecular Cell Biology at the School of Natural Sciences and Museum (National University of La Plata, Argentina). Appointed Senior Researcher of the National Scientific and Technological Research Council of Argentina. Former Member of the Executive Committee of the Latin American Association of Environmental Mutagenesis, Teratogenesis and Carcinogenesis. Author of more than 470 contributions, including scientific publications, research communications and conferences worldwide. Recipient of several national and international awards. Prof. Larramendy is a regular Lecturer at the international A. Hollaender Courses organized by the IAEMS and former guest scientist at NIH (USA) and University of Helsinki, (Finland). He is expert in Genetic Toxicology and is, or has been, referee for more than 30 international scientific journals. Member of the International Panel of Experts at the International Agency for Research on Cancer (IARC, WHO, Lyon, France) in 2015 for the evaluation of DDT, 2,4-D and Lindane. Presently, Prof. Dr. Larramendy is Head of the Laboratory of Molecular Cytogenetics and Genotoxicology at the UNLP.

Genotoxicity, Teratogenesis, Carcinogenesis, Molecular Cytogenetcis, Genetic Toxicology and Ecotoxicology

Friday E Uboh completed his PhD from University of Calabar, Calabar, Nigeria, and is presently an Associate Professor of Biochemistry, with Toxicology as his area of research interest. He served as the acting Head of Biochemistry Department in the Department of Biochemistry University of Calabar, Calabar, Nigeria, from 2011 to 2013. He is a member of Nigerian Society of Biochemistry and Molecular Biology, and Institute of Public Analysts of Nigeria. He has more than 60 papers published in reputable journals, and is a reviewer and Editorial Board Member of many journals of repute. He has also presented many conference papers locally and internationally.

Biochemistry, Toxicology and Molecular Biology, Toxicology

Dr. Izaskun Larrieta-Rubín de Celis has been lecturer at the University of the Basque Country (Spain) since 2009. Prior to this, she had worked as managing director for 17 years in a SME involved in technology innovation and software development. Her primary research interests deal with CSR and gender equality. She has defended her doctoral thesis on ‘The Management of Gendered Social Responsibility: the establishment of a framework and the implementation in companies committed to gender equality’. She has been involved in a project financed by the Spanish Ministry of Equality researching good gender practices in most gender committed Spanish companies. She has published on Gendered Social Responsibility and has proven commitment to interdisciplinary research linking CSR, gender studies, health and safety issues and corporate governance.

Her research interest includes Occupational Toxicology and Health, CSR, gender issues in workplace

Silvio De Flora, MD, PhD, was assistant Professor (1966), full Professor and chairman (1975), and Professor emeritus (2012) at the School of Medicine of the University of Genoa (Italy), where he was director for 22 years of the Institute of Hygiene and Preventive Medicine (1986-1998) and of the Department of Health Sciences (1999-2005 and 2010-2012). Author of 460 full length papers, 308 of which available in PubMed. The overall impact factor is 1500. With almost 14,000 citations, the h-index is 58. He published in collaboration with 140 laboratories in European countries, China, Japan, India, New Zealand and USA. Member of the editorial board of 16 international journals. Principal investigator of a number of research projects, 10 of which awarded by the US NIH. He received several honors, among which the award from the Michigan State University (2002), the Sobels Award (Greece, 2005), and dedication of 10th ICMAA (Brazil, 2010).

His research interest was focused on epidemiology and prevention of viral diseases until 1975. Thereafter he investigated several topics related to genomics, environmental mutagenesis and prevention of cancer and other chronic degenerative diseases, including chemoprevention of cancer and modulation of molecular biomarkers

Stefano BONASSI, born on January, 3, 1956 is a Doctor in Biological Sciences - University of Genova and a Specialist in Medical Statistics and Epidemiology - University of Pavia. He is a Faculty for PhD programs in human genetics of the Universidad Autonoma de Barcelona, Barcelona, Spain, and M2E2 International courses of Molecular Epidemiology of Chronic diseases at the Maastricht University, the Netherlands . He is a reviewer of many Journals such as Experimental Research; Mutagenesis; Cancer Epidemiology, Biomarkers & Prevention Et al.

Stefano BONASSI is interested in the use of biomarkers in human population and clinical studies. He studied chromosomal damage in the early stages of carcinogenesis and other chronic diseases. He coordinated the epidemiological part of international projects, such as ESCH on chromosome

Giovanni Pagano graduated in Biological Sciences in 1971 at Naples University and at the International Institute of Genetics and Biophysics in Naples. He served the Italian National Cancer Institute in Naples up to retirement in 2005, with a major focus on environmental toxicology. In recent years GP has collaborated with a number of national and international institutions, and lecturing at several post-graduate courses. The current positions are Research Contractor at Federico II University, and Associate Researcher at the Stazione Zoologica Anton Dohrn. GP authored over 100 publications receiving over 2000 citations; ResearchGate Score 36.63.

His research interests mainly lies in the fields of Aquatic Ecotoxicology, Genotoxicity, Biomarkers and Cytogenetics

Boris A. Katsnelson, born in 1926 (October 20) in Lugansk, Ukraina is the Head of Department of Toxicology and Biological Prophylaxis at the the Ekaterinburg Medical Research Center for Prophylaxis & Health Protection in Industrial Workers. He graduated from Сhelyabinsk State Medical College (Russia) in 1949 as a GP and received postgraduate training in occupational medicine in the same year at the Central Institute for the Postgraduate Medical Education (Moscow). During 1949 – 1954 he worked as an industrial sanitary inspector and occupational health specialist in different state agencies in Chelyabinsk. In 1954 - 1957 he received postgraduate scientific training (as a PhD student) in occupational medicine at the Moscow Institute of Industrial Hygiene and Occupational Diseases of the USSR Academy of Medical Sciences. He recently worked in the Sverdlovsk Research Institute of Industrial Hygiene and Occupational Diseases later on reorganized into the Ekaterinburg Medical Research Center.

Boris A. Katsnelson's research interest includes silicosis; pulmonary particles and nanoparticles clearance and physiologically oriented modeling of the process; toxicology with special interest in combined toxicity & nanotoxicology; occupational exposure limits for fibrogenic and toxic substances; bioprotectors against adverse health effects of occupational/environmental toxic exposures; predisposition to occupational and environmentally conditioned diseases; socioeconomic aspects of occupational and environmental medicine; occupational & environmental epidemiology

Mohamed Abou-Donia is currently working as a Professor of Pharmacology & Cancer Biology at the Duke University Basic Science Departments. He obtained his Ph.D., University of California at Berkeley 1967. He also worked as a Professor in Neurobiology, Neurobiology, Basic Science Departments. He was honored in 2004 with the Traditional Fulbright Scholarship. Council for International Exchange of Scholars.

His research interest mainly lies in understanding the basic mechanisms by which chemicals adversely affect the nervous system, which should lead to a better assessment of acute and chronic neurotoxicities and the development of drugs to prevent or treat them. His recent publications include Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: biomarkers for nervous system injury and many such sublime ones.

Diana Anderson holds the Established Chair in Biomedical Sciences at the University of Bradford. She obtained her first degree in the University of Wales and second degrees in the Faculty of Medicine, University of Manchester. She has over 450 peer-reviewed papers, 8 books, has successfully supervised 26 PhDs, and been an Editorial Boards Member of 10 international journals. She has been or is Editor in Chief of a book Series on toxicology for J. Wiley and sons and the Royal Society of Chemistry respectively. She gives key note addresses at various international meetings. She is a consultant for many international organisations, such as the WHO, NATO, TWAS, UNIDO and the OECD.

Her Research Interests Includes: cancer, oxygen radicals, human biomonitoring, unbalanced precursor pools, dietary imbalance, male-mediated developmental defects, nanotoxicology and general toxicology

Eva Cecilie Bonefeld-Jørgensen (ECB-J), Professor in Human Environmental Toxicology and Director of Center for Arctic Health (http://www.cah.au.dk/) has been the head of the research group (1 part-time professor, 1 associated professor, 1 post doc, 4 PhD students, 1 research assistant, 2 research year stud. med, 2 student assistants, 2 technical assistant, 2 thesis research student) for more than 18 years and has more than 15 years of experience in the research area of human toxicology and endocrine disruptors. ECB-J has a formal education as research leader.

Her Research Interests Include: Health and Illness , Research and Examination Methods , Environment and industrial medicine Arctic Environmental Medicine Cellular & Molecular Toxicology Endocrine disrupting chemicals Environmental chemicals thyroid hormone disruption. Health and Illness, Research and Examination Methods, Molecular medicine Arctic Environmental Medicine Mechanistic Epidemiology International Cohort studies

Marcelo L. Larramendy, Ph.D., serves as Professor of Molecular Cell Biology at the School of Natural Sciences and Museum (National University of La Plata, Argentina). Appointed Senior Researcher of the National Scientific and Technological Research Council of Argentina. Former Member of the Executive Committee of the Latin American Association of Environmental Mutagenesis, Teratogenesis and Carcinogenesis. Author of more than 470 contributions, including scientific publications, research communications and conferences worldwide. Recipient of several national and international awards. Prof. Larramendy is a regular Lecturer at the international A. Hollaender Courses organized by the IAEMS and former guest scientist at NIH (USA) and University of Helsinki, (Finland). He is expert in Genetic Toxicology and is, or has been, referee for more than 30 international scientific journals. Member of the International Panel of Experts at the International Agency for Research on Cancer (IARC, WHO, Lyon, France) in 2015 for the evaluation of DDT, 2,4-D and Lindane. Presently, Prof. Dr. Larramendy is Head of the Laboratory of Molecular Cytogenetics and Genotoxicology at the UNLP.

Marcelo L. Larramendy’s fields of research interest include genotoxicity, Teratogenesis and Carcinogenesis. His areas of expertise include Molecular Cytogenetcis, Genetic Toxicology and Ecotoxicology.

Myung-Haing Cho has completed his Ph.D in Toxicology from the University of California, Davis, USA and his M.S in Vet. Toxicology from Seoul National University, Korea. At present he is serving as a President of Korean Society of Toxicology. He is also a member at the Science and Technology Commission of Food, Agriculture, Forestry and Fisheries,Ministry for Food, Agriculture, Forestry and Fisheries, Korea.

His Research interests are mainly into the field of Toxicology, Veterinary Toxicology, Nanoparticles and Nanotechnology

Vesna Matović has completed her BSc Pharm, University of Belgrade, MSc Pharm in Toxicological chemistry at the University of Belgrade. She has done her PhD Pharm in Toxicological chemistry at the University of Belgrade. She is now serving as a Professor at Department of Toxicology “Akademik Danilo Soldatović” Faculty of Pharmacy, University of Belgrade

Her research interests include: Toxicology and ecotoxicology of metals, Interactions between heavy metals and bioelements, Toxicology and ecotoxicology of persistent organic pollutants, Mechanisms of toxicity, Oxidative stress induction and Toxicology of Mixtures.

María Concepción Gutiérrez Rui has completed her Degree in Chemistry from the Universidad Iberoamericana (1976) and her Masters of Experimental Biology at the UAM (1980). She obtained her Doctorate in Pharmacology in Research Center and Advanced Studies. She is serving as a National level III Investigator.

Her Research Interest Includes: Health Sciences, Cellular and molecular mechanisms, Pharmacology and Toxicology

Friday EUboh completed his PhD from University of Calabar, Calabar, Nigeria, and is presently an Associate Professor of Biochemistry, with Toxicology as his area of research interest. He served as the acting Head of Biochemistry Department in the Department of Biochemistry University of Calabar, Calabar, Nigeria, from 2011 to 2013. He is a member of Nigerian Society of Biochemistry and Molecular Biology, and Institute of Public Analysts of Nigeria. He has more than 60 papers published in reputable Journals, and is a reviewer and Editorial Board Member of many Journals of repute. He has also presented many conference papers, locally and internationally.

His Research interests include Biochemistry, Toxicology and Molecular Biology, Toxicology being his main focus.

Professor at Zhejiang University Institute of Respiratory Diseases, China,Hangzhou Songmin Ying was a Postdoctoral Research Scientist at the University of Oxford • Gray Institute for Radiation Oncology and Biology. He was also a Cancer Research UK China Fellow at the University of Oxford • Weatherall Institute of Molecular Medicine. He obtained his PhD from Technische Universität München Institut für Medizinische Mikrobiologie, Immunologie und Hygiene.

His fields of Research Interests Includes: Cell biology, Cancer Research, Immunology, Oncology, Infectious Diseases and Respiratory Medicines.

Omid Sabzevari (OS) is a scientist in the field of Mechanistic Toxicology and Pharmacology, Xenobiotics Analysis and Food Safety. OS was listed among Top 1% Scientists of the World according to ESI/ISI in May 2012. OS is a Temporary Adviser of WHO and a scientific member of the Expert Panel on Food Safety, JECFA. OS is President of Iranian Association of Pharmaceutical Scientists (IranAPS) and President of Iranian Society of Toxicology (IranTox). He is also the Head of Basic and Clinical Toxicology Research Centre, TUMS.

His research interests include Toxicology: Molecular Toxicology, Drug Metabolism, Hepatotoxicity, Analytical/Forensic Toxicology, Management of Poisoning and Drug Overdose: Hallucinogenics, NSAIDs, Narcotics, Opioids, Drug of Abuse Pharmacology: Pharmacokinetic, Biotransformation,, Drug Interactions, Vasoactive Peptides, Diuretics, Opioids, Endocrine Hormones, Antifungal Drugs, Drug of Abuse

Ofelia A. Olivero has pioneered the elucidation of the genotoxicity induced in pregnant women by drugs taken to prevent HIV-1 vertical transmission. The health of women during pregnancy and the wellbeing of the newborn have been her focus and concern in the quest to understand the latent toxicities that can develop into disease later in life. Her contributions helped shape the observation that AZT and other nucleoside reverse transcriptase inhibitors were responsible for DNA damage in utero and later induction of tumorigenesis in rodents. Areas of Expertise transplacental carcinogenesis, genotoxicity, nucleoside analogs, carcinogenesis

Ofelia A. Olivero is mainly interested in the field of Genotoxicity and has contributed a lot towards the same field. Her Areas of interest also include transplacental carcinogenesis, nucleoside analogs, carcinogenesis

Marcelo L. Larramendy, Ph.D. is Professor of Molecular Cell Biology, La Plata National University, Argentina. He is Principal Researcher, National Scientific and Technological Research Council of Argentina since 1981, former member of the Executive Committee of the Latin American Association of Environmental Mutagensis, Teratogenesis, and Carcinogenesis, author of more than 400 scientific papers in the field, including scientific publications in reviewed journals, research papers and conferences worldwide. He is recipient of several national and international awards, regular Lecturer at The International A. Hollaender Courses by the IAEMS, Former Guest Scientist at NIH, USA and University of Helsinki, Finland, and Expert in Molecular Cytogenetcis, Genetic Toxicology and Ecotoxicology.

Marcelo L. Larramendy’s fields of research interest include genotoxicity, Teratogenesis and Carcinogenesis. His areas of expertise include Molecular Cytogenetcis, Genetic Toxicology and Ecotoxicology.

Gerhard Eisenbrand is Professor Emeritus at the University of Kaiserslautern, Department of Chemistry, Division of Food Chemistry and Toxicology. His research waspublished in more than 350 peer reviewed scientific publications. He mainly focuses on mechanisms of actions of (geno) toxic and various anticancer agents, metabolism and biokinetics, recent and current research interactions of food constituents/contaminants with biomolecules in the organism, within the context of food safety and beneficial/ adverse effects relevant to human health, in experimental and human intervention studies. He was long acting (1995 to 2013) chair of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG) and is currently Scientific President of ILSI Europe.

Gerhard Eisenbrand’s fields of research interest include studies on mechanisms of actions of (geno) toxic and various anticancer agents, metabolism and biokinetics. His current research is upon interactions of food constituents/contaminants with biomolecules in the organism, within the context of food safety and beneficial/ adverse effects relevant to human health, in experimental and human intervention studies.

Myung-Haing CHO is the President of Asian Society of Toxicology.

Toxicology is the main field of research interest of Myung-Haing Cho

Tatyana Borovskaya has graduated from the Tomsk State Medical University got Doctoral degree and completed her postdoctoral studies from the Goldberg Research Institute of Pharmacology. She is the head of Laboratory of Pharmacology. She has published 3 monographs, more than 160 papers in reputed journals and is the author of 14 patents. The field of interests covers toxicology, andrology and embryology.

Tatyana Borovskaya fields of research interest covers toxicology, andrology and embryology.

Ü Ündeğer Bucurgat has completed her PhD in 2001 from Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology (Turkey). She is currently working in the same department as Professor. She studied in Albert Szent Györgyi University, Hungary in 1998 as Researcher during her doctorate. She studied in Zurich University in 2002 and Dortmund University in 2004 as Post doctorate researcher. She has 35 article indexed in Science Citation Index and 629 citations for her publications.

Ü Ündeğer Bucurgat’s main field of interest is Toxicology in which she is pursuing her current research works.

Ying Peng has completed his Ph.D at the age of 31 years old from Schoolof Medicine, Sun Yat-Sen University,Guangzhou,China and finished his postdoctoral traininginNational Cancer Institute-at Frederick, NIH, MD, USA. He is aDirector and Professor of Department of Neurology, Sun Yat-Sen Memorial Hospital, SunYat-Sen University. As a clinical neurologist,he has published more than 85 papers in reputed journals and serving as an Associate- Editor-in-Chief of “Chinese Journal of Nervous and Mental Disease” , Deputy- Chief of Neuro-pharmacologicalAssociation of Guangdong province, and Deputy- Chief of Neurological division of Doctor Association of Guangdong province,China.

Ying Peng’s field of research institute encompasses Neurology, Toxicology and Clinical Trails.

Simona Clichici is associate professor at the Department of Physiology, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, Romania. She is the coordinator of the In Vivo Research Laboratory at this Physiology Department. She has practical experience and many published papers concerning in vivo experimental design of different pathological conditions, oxidative stress and cytotoxicity assessment, study of the nanomaterials effects on living organisms, protective effects of different natural compounds, photodynamic therapy and carcinogenesis. She was the coordinator of 2 national grants regarding toxicological studies and she is the author/co-author of 45 ISI papers, all of them concerning experimental and toxicological studies on lab animals.

Simona Clichici’s mainly focuses her research work upon In Vivo technologies. She has also published many papers concerning in vivo experimental design of different pathological conditions, oxidative stress and cytotoxicity assessment, study of the nanomaterials effects on living organisms, protective effects of different natural compounds, photodynamic therapy and carcinogenesis.

Amita Srivastava working as Poison Information Consultant in the National Poisons Information Centre of AIIMS has completed her PhD degree at the age of 29 years from Indian Institute of Technology, Kanpur, India. She has published a number of papers in national and international journals. She is a life member of Society of Toxicology, India and also the member of Indian Society of Toxicology. She is in the panel of reviewing committee of Indian Journal of Pharmacology. She has been co-guide of many PhD students of AIIMS. She has a rich experience of handling sophisticated laboratory instruments like Inductively Coupled Plasma and Atomic Absorption Spectrophotometer.

Amita Srivastava’s field of research interest includes Toxicology and Pharmacology. She also shares her interest upon various aspects of of handling sophisticated laboratory instruments like Inductively Coupled Plasma and Atomic Absorption Spectrophotometer.

Friday E. Uboh completed his Ph.D at the age of 35 from University of Calabar, Calabar, Nigeria, and is presently an Associate Professor of Biochemistry, with Toxicology as his area of research interest. He served as the acting Head of Biochemistry Department in the Department of Biochemistry University of Calabar, Calabar, Nigeria, from 2011 to 2013. Dr. Uboh is a member of Nigerian Society of Biochemistry and Molecular Biology, and Institute of Public Analysts of Nigeria. He has more than 60 papers published in reputable Journals, and is a reviewer and editorial board member of many Journals of repute. He has also presented many conference papers, locally and internationally.

Friday E Uboh main fields of interest include Biochemistry, Toxicology and Molecular Biology, Toxicology being his main focus.

Kyle Kolaja is currently Vice President, Business Development at Cellular Dynamics, International, a leading developer of stem cell technologies for in vitro drug development, in vivo cellular therapeutics, and stem cell banking. In this role, Dr. Kolaja leverages his 15 years of pharmaceutical experience as a toxicology thought leader to seek and establish novel preclinical and clinical applications of pluripotent stem cells and their derived tissues. Prior to joining CDI, Dr. Kolaja was Leader/Global Head of Predictive Toxicology Screens and Investigative Toxicology at Roche, where he oversaw laboratories in US and Europe that conducted all safety screening assays, provided toxicology support to projects, and applied stem cell derived tissues to safety. Prior to joining Roche, Dr. Kolaja was Vice President of Chemogenomics and Toxicology at Iconix Pharmaceuticals and prior to that, was a project toxicologist and site head of investigative toxicology at Searle/Pharmacia. Dr. Kolaja has served as President of the Society of Toxicology's Drug Discovery Toxicology Specialty Section, is currently President of the Stem Cells and Toxicology Specialty Section, and previously served on the Board of Directors for the American Boards Of Toxicology. Dr. Kolaja is currently an Associate Editor of the SOT's Journal Toxicological Sciences. Dr. Kolaja has nearly 70 peer-reviewed publications and reviews including 12 on applications of stem cell derived tissues in early safety, received his BS from Michigan State University and his Ph.D. in Toxicology from Indiana University (mentor James Klaunig) and conducted his post-doctoral research at the University of Kansas (mentor Curt Klaassen).

Douglas Fuhrer is a strategic consultant for medical device, small molecule and biologic therapeutic programs and was a Director of Toxicology and Pharmacology in established Biotechnology companies. He has over fifteen years experience with hands-on applications including directing teams of scientists and technicians in CRO, Large Pharma and Biotech organizations. His training and experience also includes applied animal investigation skills as a study director of GLP toxicology and safety pharmacology studies. He has completed multiple successful INDs and non-clinical programs supporting clinical development and leading to strong regulatory submissions of preIND briefing packages, INDs, NDAs and global equivalents. He has advanced treatments in the therapeutic areas of anti-infectives, cancer, immune regulation, diabetes, CNS, prostate enlargement, and hepatitis C. Recently he provided critical support which led to the FDA advisory committee approval of an anti-fibrotic drug. He is also expert at writing risk assessment report in support of extractable leachable studies he received his Bachelor’s and Master’s of Science degrees in Biological Sciences from Northern Illinois University and his Ph.D. in Biochemistry from the University of Illinois at Urbana-Champaign. His academic work focused on signal transduction mechanisms and he is board certified in toxicology (DABT). Memberships he has include the Society of Toxicology, Safety Pharmacology Society, and American Association of Pharmaceutical Scientists. He is also a founder and manager of the LinkedIn Biopharma Interest Group (BIG).

Intracellular components of signal of transduction are both therapeutic targets and targets of toxicity. The translation of a plethora of activating and inhibiting signals by a cell signals a cumulative response which can help bring a body back to reach cellular and systemic homeostasis. Understanding cellular specific mechanisms of signal transduction allows the development of target focused pharmaceuticals and avoidance of off-target responses. Predictive toxicity programs, in vitro assays and animal therapeutic models can only provide limited clinical efficacy and safety information. A harmonization of all available signaling information allows the dissection of pathways to identify targets of limited cross-talk to other critical signaling cascades. When in the process of regulatory safety assessment studies, by understanding cellular signal transduction unexpected, an optimized therapeutic index with an immaculate report is possible. The ability to understand and distinguish similarities and differences between toxicity species and the clinic is also central to this application, leading to quick first in man studies and clean clinical trials.

Pavel Vodicka graduated at the Medical Faculty, Charles University, Prague and in 1986 obtained PhD in biochemistry. He worked as visiting scientist at the Finnish Inst. Occupat. Health, Helsinki, Finland (1987-1990) and at Karolinska Institute, Huddinge, Sweden (1990-1993). Since 2002 he is a head of the Dept. Molec. Biol. Cancer, Inst. Exper. Medicine, Acad. Sci., Prague, Czech Republic. Pavel Vodicka has published more than 120 (2670 citations, HI 31) articles. His main research topics were carcinogenic effects of industrial monomers, DNA and chromosomal damage and DNA repair functional tests in humans and dissection of transient biomarkers in the onset of gastrointestinal cancers. He edited the Special Issue (2012) in Mutagenesis (http://mutage.oxfordjournals.org/content/27/2.toc), entitled Colorectal Cancer-Current Insights into Susceptibility.

Ramesh C. Gupta, Professor and Head of Toxicology Department, is engaged in experimental brain research in relation to Alzheimer’s disease (AD) and pesticide toxicity. He has delivered lectures in Australia, Italy, Japan, Germany, France, Finland, Switzerland, Sweden, Spain, Czech Republic, South Korea, and China. He served the panels of NIH, CDC, NIOSH, and NAS. He has >300 publications, including six books: (1) Toxicology of Organophosphate and Carbamate Compounds, (2) Veterinary Toxicology: Basic and Clinical Principles, (3) Handbook of Toxicology of Chemical Warfare Agents, (4) Anticholinesterase Pesticides: Metabolism, Neurotoxicity and Epidemiology, (5) Reproductive and Developmental Toxicology, and (6) Biomarkers in Toxicology. He is recipient of Murray State University\'s distinguished researcher award of the year-2006. He is a diplomate of ABT, and fellow of American College of Toxicology, American College of Nutrition, and Academy of Toxicological Sciences.

Rajat Sethi received his Ph.D. from the Department of Medicine, University of Manitoba, Canada. Sethi is currently the chair of Department of Pharmaceutical and Biomedical Sciences at the California Health Sciences University, Clovis, California. Prior to this, he served as the assistant dean for Research and Evidence Based Practice at the Texas A&M Health Science Center. He has more than 100 publications in the field of cardiac toxicology, holds 18 patents, has authored 7 books, and serves in the editorial board for many journals. He has received grants from federal and local agencies and from various foundations and has been an invited speaker in many national and international meetings and he is the recipient of numerous awards and honors for his contribution to research and education.

Pharmaceutical Sciences

María Ángeles Esteban, Professor of Cell Biology and Histology at the Faculty of Biology, University of Murcia (Spain). Vicedean of the Faculty of Biology (2005-2006) and Vice-Rector of the University of Murcia (2006-present). Author of more than 125 scientific papers in prestigious international journals. Expert in fish immunology and focus her work on immunostimulation by natural products and immunodepression (caused by infectious diseases or pollutants) on fish with interest in the Mediterranean aquaculture.

Marcelo Larramendy, Ph.D., Professor of Molecular Cell Biology, La Plata National University, Argentina. Principal Researcher, National Scientific and Technological Research Council of Argentina since 1981. Former Member of the Executive Committee of the Latin American Association of Environmental Mutagensis, Teratogenesis, and Carcinogenesis. Author of more than 400 scientific papers in the field, including scientific publications in reviewed journals, research papers and conferences worldwide. Recipient of several national and international awards. Regular Lecturer at The International A. Hollaender Courses by the IAEMS. Former Guest Scientist at NIH, USA and University of Helsinki, Finland. Expert in Molecular Cytogenetcis, Genetic Toxicology and Ecotoxicology.

Toxicology

Frederic J. Deschamps, Medical doctor (Lille- France University in 1990) He is PhD in occupational Toxicology for 1993. He was nominated professor of Medicine in 2002. He has improved for the last 20 years the department of occupational diseases of the university hospital of Reims (Champagne County). He manages for 1995 the Regional Institute of Occupational Health. He belongs to the French National University College of occupational Researches and Practionners. He has focused his work an occupational infectious diseases and health effects of low doses toxics with long term exposure.

toxicology

I am currently employed at Pesticide Chemistry Department, NRC, Cairo, Egypt where I have been working since 1995. I have awarded PhD in 2005, from Zoology Dept., Faculty of Science, Cairo University. The thesis title is “Toxicological Studies on Pregnant Rats Exposed to Pesticide Mixtures and Antioxidants”. The focus of my research in the last few years is the investigation of the hepatotoxic, nephrotoxic and reproductive toxicities of some environmental pollutants including pesticides on rat. However, seeking and testing many materials of antioxidant activities were evaluated for their ameliorating effects. I have been primary author or co-author on several research papers published in accredited journals dealing with hepatoprotective effects.

Environmental Toxicology

Abdel-Tawab H. Mossa has received his completed PhD on Pesticide Chemistry and Toxicology in Alex. University. Currently, he is working as Associate Professor in Environmental Toxicology Research Unit (ETRU), Pesticide Chemistry Department, National Research Centre, Egypt. Dr. Mossa has more than 35 research published in national and international scientific journals. He is Editor in 10 international journals and Reviewer in more than 15 pree reviewed international journals. He is a member of Egyptian Society of Toxicology and the Arab Society of Medicine.

Environmental Toxicology

Manar Effat Selim has completed his Ph.D. at the age of 34 years from Ain Shams University and postdoctoral studies from Ain Shams University Faculty of Science. She has published more than 21 papers in reputed journals and serving as an editorial board member of repute.She has many rewards in her career(molecular embryology).

John Pierce Wise, Sr. is currently Professor of Toxicology and Molecular Epidemiology, the Director of the Maine Center for Toxicology and Health and the head of the Wise Laboratory of Environmental and Genetic Toxicology at the University of Southern Maine. He holds a Ph.D. in pharmacology focused on metal carcinogenesis from the George Washington University. He completed a postdoctoral fellowship in molecular epidemiology at the National Institutes of Health (NIH), which led to a faculty position as an Assistant Professor at Yale University. After several years at Yale, Wise joined The University of Southern Maine.

Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts, Mechanisms of Altered Gravity Potentiation of Metal-Indued, Genotoxicity, Toxicology of Metal and Lunar Particles in Biological Systems, Genotoxicity and Carcinogenicity of Particulate Depleted Uranium

Vasilis Vasiliou is currently working as a Professor in the Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Denver, USA.

Toxicology

Fang Liu is a scientist in the Division of Neurotoxicology, National Center for Toxicological Research (NCTR)/United States Food & Drug Administration. Dr. Liu has been actively involved in biomedical research for more than ten years and has been an author and a co-author for more than 30 peer-reviewed scientific articles and book chapters in the areas of pharmacology, toxicology and molecular biology. Currently, she focuses her research on developmental neurotoxicity. She is a full member of the Society of Toxicology, Society for Neuroscience and the Arkansas Chapter of the Society for Neuroscience. She is also an editor and a reviewer of several reputed peer-reviewed journals.

Neurotoxic effects of anesthetics on developing brain, using in vitro, in vivo models, including stem cell-based models to evaluate the neurotoxicity of anesthesia during development, to delineate the mechanisms and search for approaches/agents to prevent or minimize the toxic effects.

Zheng is a Professor of Toxicology and the Head of School of Health Sciences at Purdue University. He is a recognized researcher in the fields of metal-induced neurodegenerative disorders such as Mn-caused Parkinsonism andPb-associated cognitive deficiency. Zheng received his Ph.D. in Toxicology from University of Arizona. He was an Assistant/Associate Professor at Columbia University (1993-2003) and joined Purdue in 2003. Zheng has served in various NIH study sectionsand journal editorial board, and published one book, 137 research manuscripts. His research has been supported by NIH/NIEHS (since 1994), Dept of Defense and awards from pharmaceutical companies.

Xia Huo has received her PhD in The First Military Medical University during the period of 1998. Currently, she is working as Professor and Director of Analytical Cytology Lab in Chief of Research Administration Office Shantou University Medical College. She has successfully completed her Graduate Training in Anatomy, Histology and Embryology in Guangxi Medical University, China. She is serving as an editorial member of several reputed journals likeChinese Journal of Histochemistry and Cytochemistry.

Environment medicine, toxicology and epidemiology with special focuses on the developmental effects of prenatal and early postnatal exposure to environmental pollutants in infants and children. Assess health hazards and outcomes in populations exposed to environmental toxicants. The relationship and mechanism of environmental pollutants and disease.

Rajat Sethi completed his Ph.D. in Physiology from University of Manitoba, Canada and is currently the Assistant Dean for Research and Evidence Based Practice at the Texas A&M Health Science Center- College of Nursing. He has published more than 30 peer reviewed papers in cardiac pathology, holds 15 patents, has authored 5 books and serves in the editorial board for many journals.

Abdel-Tawab H. Mossa has received his completed Ph.D on Pesticide Chemistry and Toxicology in Alex. University. Currently, he is working as Associate Professor in Environmental Toxicology Research Unit (ETRU), Pesticide Chemistry Department, National Research Centre, Egypt. Dr. Mossa has more than 30 research published in national and international scientific journals. He is Editor in 8 international journals and Reviewer in more than 15 pree reviewed international journals. He is a member of Egyptian Society of Toxicology and the Arab Society of Medicine.

Toxicology

Christine Nellemann is head of the Division of Toxicology and Risk Assessment at the National Food Institute, Technical University of Denmark. The Division of Toxicology and Risk Assessment works on promoting health and preventing illness by performing research, teaching and advising authorities on the human effects of chemical substances and naturally occurring compounds in our food and environment. The Division employs approximately 70 employees and offers an inspiring working environment. The research of Division of Toxicology covers many areas from reproductive toxicology, endocrine disruption, cancer, nanotoxicology, risk-benefit evaluations, food allergy and QSAR. The researchers use human samples, animals as well as cellular and computer models in order to predict the effects of chemicals in humans.

Cheng Wang, M.D., Ph.D. is a Senior Scientist at the National Center for Toxicological Research (NCTR)/US Food and Drug Administration (FDA). He is also an Adjunct Faculty member in the Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences (UAMS). He is currently the P.I. on 4 research protocols supported by the NCTR/FDA, National Toxicology Program and NICHD. He is currently responsible for leading a research team that provides unique and highly specialized skills in toxicology, pharmacology, stem cell biology and systems biology research. He has published about 60 peer-reviewed research articles in prestigious journals and 10 book chapters. He is an Editor-in-Chief of the book entitled “Developmental Neurotoxicology Research: Principles, Models, Techniques, Strategies, and Mechanisms.” He also serves on the editorial board of 3 reputed journals and as a reviewer of 10 other journals. He was awarded the Outstanding Performance Award at the Society of Toxicology 44th Annual Meeting and the 2007 FDA Scientific Achievement Award for Excellence in Laboratory Science. He also was awarded a 2008 FDA Group Recognition Award for his participation in the Pediatric Anesthesia Research Group.

To minimize the risks to children resulting from the use of anesthesia; by using in vitro, in vivo, stem cell-derived models and preclinical research approaches (including molecular imaging, pharmacogeneomic/system biology approaches) to assess the neurotoxicity and to allow for the confirmation of toxicological outcome and biological pathways of anesthetic-induced cell death in the developing nonhuman primates and rodents.

Tarek Heikal has received his PhD in Cairo University during the period of 2005. Currently, he is working as Associate Professor of Narcotics and Poisons in Environmental Toxicology Research Unit. He has successfully completed his Administrative responsibilities as Research Assistantin Chemical Industries Research Division. He is member of Egyptian Society of Toxicology.

Toxicity evaluation of different environmental pollutants on experimental animals and studying their hazard effects, where, behavioral signs, biochemical parameters, growth rate, hormonal assay disrupters, amino acids concentration disturbance, histology, as well as DNA damage (Comet assay) were the criteria for the manifestation of such hazards. Recently, Interests with the interaction between drugs and toxins such as pesticides, and the role of antioxidants (natural or synthetic origin) in ameliorating the hazards of pollutants. Using medicinal plant extracts of Hypericm perforatum as antidepressant drugs.